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ABSTRACT  N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase (GalNAc4S-6ST) is an enzyme
which is known to help build up the GlcAβ1-3GalNAc(4,6-bisSO4) unit of chondroitin sulfate E (CS-
E). This enzymatic activity has been reported in squid cartilage and in human serum, but has never
been reported as an enzyme required during early mouse development. On the other hand, CS-
E has been shown to bind with strong affinity to Midkine (MK). The latter is a heparin-binding
growth factor which has been found to play important regulatory roles in differentiation and
morphogenesis during mouse embryonic development. We have analyzed the expression pattern
of the GalNAc4S-6ST gene during early mouse embryonic development by whole mount in situ
hybridization. The results show that GalNAc4S-6ST is differentially expressed in the anterior
visceral ectoderm at stage E5.5 and later becomes restricted to the embryonic endoderm,
especially in the prospective midgut region. During the turning process, expression of GalNAc4S-
6ST gene is detected in the forebrain, branchial arches, across the gut tube (hindgut, midgut and
foregut diverticulum), in the vitelline veins and artery and in the splanchnopleure layer. These
results open the possibility of a role for GalNAc4S-6ST during early mouse development.
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N-Acetylgalactosamine 4-sulfate 6-O-sulfotransferase
(GalNAc4S-6ST; EC 2.8.2.33) is a Golgi-resident enzyme that
transfers sulfate from 3´-phosphoadenosine 5´-phosphosulfate
(PAPS) to the C-6 hydroxyl group of N-acetylgalactosamine 4-
sulfate. N-acetylgalactosamine 4,6-bissulfate is a component
sugar residue of the repeating disaccharide unit, GlcAβ1-
3GalNAc(4,6-bisSO4), in chondroitin sulfate E (CS-E) (Suziki et
al., 1968). CS-E was found in various mammalian cells as well as
in squid cartilage (Habuchi et al., 1971) and shows some activity
in mast cell maturation (Eliakim et al., 1986), regulation of
procoagulant activity of monocytes (McGee et al., 1995), promo-
tion of neurite outgrowth (Clement et al., 1999), neural adhesion
through binding to Midkine (Ueoka et al., 2000) and enhancement
of plasminogen activation (Sakaia et al., 2000). Interestingly, CS-
E has been shown to bind with strong affinity to Midkine (MK) (Zou
et al., 2003), that together with heparin-binding growth-associ-
ated molecule (HB-GAM or pleiotrophin) forms a family of hep-
arin-binding growth factors. These two proteins can be found
during mouse embryonic development playing regulatory roles in
differentiation and morphogenenetic processes (Mitsiadis et al.,
1995).
It has also been shown that the nucleotide sequence of human
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GalNAc4S-6ST is nearly identical to that of human B cell RAG-
associated gene (hBRAG), which raises the interesting possibility
that GalNAc4S-6ST might be involved in maturation of B cells by
regulating the recombination activating gene 1 (RAG1) (Ohtake et
al., 2001). RAG1 plays an important role in V(D)J recombination
and expression analysis indicates that hBRAG is coordinately
expressed with RAG1 in human pro- and pre-B cell lines (Verkoczy
et al., 1999). The homology between human and mouse GalNAc4S-
6ST might suggest a similar function.
In the present study, we show that the GalNAc4S-6ST gene is
expressed in the anterior visceral endoderm (AVE) and is there-
fore likely to have an active role during early mouse development.
The AVE comprises a population of primitive endoderm cells
located at the distal tip of the 5.5 dpc (days post coitum) embryo,
which undergo differentiation and migration to the prospective
anterior region and have been reported to be involved in the
establishment of the anterior-posterior (AP) axis (Rossant and
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Tam, 2004). The process of neural AP patterning involves the
integration of various signals such as retinoic acid (RA), fibroblast
growth factors (FGF) and members of the Wnt family as well as
the inhibition of BMP-4, Nodal and Wnt8 signaling (Piccolo et al.,
1999; Glinka et al., 1997; Silva et al., 2003).
To elucidate the developmental aspect of GalNAc4S-6ST
function, the expression pattern of GalNAc4S-6ST mRNA was
analysed by in situ hybridization during mouse embryonic devel-
opment.
The expression of GalNAc4S-6ST is first detected in the AVE
at pre-streak stage (Fig. 1A) and continues throughout gastrula-
tion and neurulation (Fig. 1). At mid-streak stage (Fig. 1B), in
addition to the the AVE, a weak expression can be observed in the
mesoderm cells arising from the anterior primitive streak. In the
late-streak embryo (Fig. 1C) the expression becomes restricted to
anterior definitive endoderm (ADE) corresponding to the foregut
endoderm. At E7.0, expression can be found in the most rostral
edges of the ADE fold and fuse ventromedially forming the foregut
pocket and the GalNAc4S-6ST mRNA expression follows this
process. There is a strong staining in the endoderm cells lining the
foregut diverticulum and in the prospective midgut as shown in
Fig. 2 C1, C2 and C3.
During the turning sequence, at stage E8.5 (Fig. 2D), it’s
possible to observe expression in the neuroepithelium of the
prospective forebrain region, being particularly stronger in the
dorsal aspects of the neural folds (Fig. 2 D1,D2). There are some
signals of expression in the pharyngeal region of the foregut
diverticulum but only in the ventral endoderm foregut diverticulum
specifically in the buccopharyngeal membrane (Fig. 2 D3). At this
stage GalNAc4S-6ST is also expressed in the body wall overlying
the pericardial cavity as well as along the entire embryo in the
vitelline veins region (Fig. 2 D,D4). A transverse section through
a region where the neural tube is already closed shows staining
in the endoderm continuous with the yolk sac (Fig. 2 D5). Trans-
verse sections of the tail region reveal a strong expression in in the
ventral endoderm cells of the hindgut diverticulum, in the adjacent
vitelline artery and in the endoderm continuous with the yolk sac
(Fig. 2 D6).
Once the turning process is completed, it became clear
which cells express GalNAc4S-6ST (E9.5). A continuous do-
main of expression that extends along the ventral region of the
embryo’s trunk, can be seen by whole mount in situ hybridiza-
tion (Fig. 2E), while in the forebrain expression becomes
restricted to the dorsal aspect of the neural folds (Fig. 2 E1). At
this stage GalNAc4S-6ST mRNA is detected in the epithelium
of the future mandibular component of the first branchial arch
(Fig. 2, E2). There is some expression in the body wall under-
lying the pericardial cavity adjacent to the septum transversum
(Fig. 2, E4). Less pronounced but still evident is the expression
in the somites at tail and heart level, being excluded from the
rest of embryo body (Fig. 2 E3,E5). In the tail region, several
tissues express GalNAc4S-6ST. There is staining in the ventral
endoderm of the hindgut diverticulum adjacent to the vitelline
artery, in the mesodermal cells that contact with the so-
matopleure layer and in the splanchnic mesoderm, also de-
tected in the midgut region (Fig. 2 E5, E6).
The oldest embryos analyzed had reached 30-34 somite
stage (E10.0) and the observed expression pattern of GalNAc4S-
6ST is similar to that described for the previous stage (Fig. 2F).
Coronal sections (Fig. 2 F1, F2 and F3) show that GalNAc4S-
6ST continues to be ventrally expressed in the vitelline artery,
in the gut endoderm, in splanchnopleure layer and in the
mesendermal cells in contact to somatopleure layer. GalNAc4S-
6ST expression is also maintained in the epithelium of the first
branchial arch and in the roof plate of the forebrain (Fig. 2 F,
F1).
Our results show that GalNAc4S-6ST displays a dynamic
expression pattern during early mouse development. The ex-
pression is first detected in the AVE, a tissue that plays a central
role in the establishment of the anterior-posterior axis. Later
expression is shown to be mainly localized in the embryonic
endoderm lining the gut diverticulum, which persists until E10.0.
Concurrently with the turning process, GalNAc4S-6ST is ex-
pressed in a few, supposedly unrelated, structures such as the
first branchial arch and the presumptive roof plate of the
forebrain. GalNAc4S-6ST is an enzyme involved in the biosyn-
Fig. 1. Expression pattern of N-Acetylgalactosamine 4-sulfate 6-O-
sulfotransferase mRNA from gastrulation to neurulation. Whole
mount in situ hybridization with a GalNAc4S-6ST DIG-labelled antisense
RNA probe was performed on embryos from pre-streak to head-fold
stages. Lateral view. (A) The expression of GalNAc4S-6ST mRNA at pre-
streak stage (E5.5) is visible in the AVE. (B) Primitive streak establish-
ment and AVE migration to the prospective anterior region. GalNAc4S-
6ST is expressed in the AVE and in mesendoderm cells arising from the
anterior primitive streak, as can be seen by the staining from the distal tip
to the anterior region. (C) At stage E7.0, the expression of GalNAc4S-6ST
became restricted to the anterior definitive endoderm corresponding to
the presumptive foregut endoderm. (D) Expression pattern at neural
plate stage. GalNAc4S-6ST is expressed in the definitive endoderm cells
underlying the prospective head-fold. Abbreviations: ADE, anterior de-
finitive endoderm; AVE, anterior visceral endoderm; ps, primitive streak.
endoderm (Fig. 1D) that spread laterally underlying the prospec-
tive head-fold region during the neural plate stage and later will
fuse medially originating the ventral foregut tube.
Head-fold stages are represented by E7.25, E7.5 and E8.0
embryos. At early head-fold stage (Fig. 2A) the expression of
GalNAc4S-6ST mRNA is located to the more rostral ADE as it
spreads laterally, while being completely excluded from the
midline. Transverse sections of an E7.5 embryo show staining in
the definitive endoderm and in the intra-embryonic mesoderm
subjacent to the caudal part of the head-fold (Fig. 2 B1,B2). Some
expression in the extra-embryonic mesodermal component of the
visceral yolk sac, more specifically in the aggregation of tissue
which will subsequently form erythroblast cells (Fig. 2 B1, red
arrowheads), is also detected. There is no expression in the
notochordal plate, neuroepithelium nor in the cephalic meso-
derm. At the late head fold/early somite stage (Fig. 2C) the lateral
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Fig. 2. Expression pattern of N-
acetylgalactosamine 4-sulfate 6-O-
sulfotransferase mRNA from neuru-
lation to midgestation. Whole mount
in situ hybridization performed in mouse
embryos at stages E7.25 – E10.0. All
sections are 8-µm. (A) Anterior view.
Early head-fold embryo (E7.25) reveals
an expression in the more rostral ADE.
(B) Lateral view. Stage E7.5. The trans-
verse sections taken at the head-fold
level show that GalNAc4S-6ST is ex-
pressed in the definitive endoderm cells
and in the intra-embryonic mesoderm
subjacent to the caudal part of the head-
fold (B1, B2) as well as in the extra-
embryonic mesodermal component of
the visceral yolk sac (B1, red arrow-
heads). (C) Anterior view. Whole mount
in situ hybridization performed at stage
E8.0. (C1,C2, C3) is a sequence of
transverse sections that shows a re-
stricted expression in the definitive en-
doderm around the foregut diverticu-
lum (pocket). (D) Ventral view. At stage
E8.5, a dynamic pattern of GalNAc4S-
6ST expression can be detected.
GalNAc4S-6ST is expressed in the pro-
spective forebrain neural folds (D1,D2),
in the foregut diverticulum (D3) and in
the body wall at the pericardial cavity
(D4). In the region where the neural
tube is closed, GalNAc4S-6ST expres-
sion is visible in the endoderm continu-
ous with the yolk sac (D5). Embryo tail
level section (D6) shows expression in
the vitelline artery and in the ventral
endoderm of hindgut diverticulum. (E)
Lateral view. Expression pattern of
GalNAc4S-6ST at stage E9.0. There’s
expression in the prospective forebrain
neural folds (E1), in the first branchial
arch (E2), in the endocardial cells adja-
cent to the septum transversum (E4),
in splanchnic mesoderm, vitelline ar-
tery, hindgut diverticulum and in the
endoderm in contact with the somatopleure layer (E6). In addition, weak GalNAc4S-6ST expression was detected in the somites at the tail and heart
region (E3,E5). (F) Lateral view. Whole mount–in situ hybridization performed at stage E10.0 (F1-3, anterior is to the top). (F1,F2,F3) are coronal
sections which show strong staining in the branchial arches in the midgut diverticulum, in the vitelline artery, in the splanchnopleure layer and in the
endoderm cells in contact with the somatopleure layer. Abbreviations: ADE, anterior definitive endoderm; aip, anterior intestinal portal; ba, branchial
arch; bw, body wall; cip, caudal intestinal portal; cnf, cephalic neural fold; ecc, endocardial cells; ed, endoderm; fgd, foregut diverticulum; fgmg, foregut-
midgut junction; hf, head fold; hgd, hindgut diverticiulum; mgd, midgut diverticulum; ms, mesoderm; nf, neural fold; np, notochord plate; nt, neural
tube; pp, prechordal plate; sm, somite; smp, somatopleure layer; spp, splanchnopleure layer; va, vitelline artery; vv, vitelline vein; ys, yolk sac.
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thesis of glycosaminoglycans and the activity of several growth
factors, such as the FGF class, depends on the interaction with
proteoglycans via their glycosaminoglycans side chains. It can
be argued that GalNAc4S-6ST may play a role in differentiation
and morphogenenetic processes during embryonic development
by serving as a regulatory point in the production of CS-E, which
has been shown to interact and modulate the activity of the
heparin-binding growth factor MK.
Experimental Procedures
Gene expression profiling using GeneChips ® (Affymetrix ®)
led to the identification of several transcripts differentially ex-
pressed in the mouse AVE (Filipe et al., unpublished results).
Among them, mouse GalNAc4S-6ST mRNA was identified as
being upregulated in the AVE gene pool. The full-length clone of
mouse GalNAc4S-6ST (accession number: AV322573), contain-
ing the entire coding sequence as well as the 5’ and 3’-UTR, was
acquired from RZPD® (4631426J05Rik). Mouse embryos were
obtained by crossing B6SJL/F1 hybrids maintained on a 7pm to
5am dark cycle and mated overnight. Noon of the day on which a
vaginal plug was observed was considered 0.5 dpc. Embryos
were dissected from the uterus in PBS and staged by morphologi-
cal landmarks (Downs and Davies, 1993). Embryos were fixed
overnight at 4°C in 4% paraformaldehyde, dehydrated through a
graded methanol series and stored at -20°C until use. Whole
mount in situ  hybridization and antisense-probe preparation were
performed as previously described (Belo, 1997). Digoxigenin
labeled GalNAc4S-6ST mRNA probe was synthesized by linear-
izing the AV322573 clone with EcoRI and transcribing with T7
RNA polymerase. The probe was run on a 2% agarose gel before
use to verify yield and length. After staining, embryos were re-
fixed in 4% paraformaldehyde and photographed using a Leica
DFCM20 digital camera. Some embryos were embedded in
paraffin and sectioned at 8 µm using a Leica RM2135 microtome.
The sections were examined and photographed using a Leica DM
MB2 microscope and a Leica DFCM20 digital camera.
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